Test Price
2,800 AED✅ Home Collection Available
SOST Gene Sclerosteosis Type 1 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل الحمض النووي لجين SOST لتصلّب العظام النوع الأول بتقنية التسلسل من الجيل التالي (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
الملخص التنفيذي: فحص دقيق وشامل لجين SOST وفق أعلى معايير هيئة الصحة بدبي، مع خدمة سحب منزلي متميزة، ودعم سريري بعد النتيجة.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Comprehensive NGS Analysis for Sclerosteosis Type 1
This test uses Next‑Generation Sequencing (NGS) to fully analyse the SOST gene, detecting pathogenic variants responsible for the rare autosomal recessive bone disorder Sclerosteosis type 1. The result provides essential diagnostic and prognostic information for paediatric, orthopaedic, and genetic management.
يستخدم هذا الفحص تقنية التسلسل من الجيل التالي لتحليل جين SOST المسؤول عن مرض تصلب العظام الوراثي النادر من النوع الأول، موفراً معلومات تشخيصية حاسمة لإدارة الحالة.
| Feature | Our Test (NGS SOST) | Sanger Sequencing | Whole Exome Sequencing |
|---|---|---|---|
| Precision | Full gene coverage, detects novel variants, >99.9% sensitivity | Limited to known hotspots, may miss large deletions | Broad capture but lower depth for SOST, incidental findings risk |
| Methodology | Next‑Generation Sequencing (NGS) | Capillary Electrophoresis | NGS with Exome Capture |
| Turnaround Time | 3–4 Weeks | 2–4 Weeks | 6–10 Weeks |
Physician Insight & Safety Protocol
“I am Dr. Prabhakar Reddy, DHA‑licensed physician (License No. 61713011). This highly sensitive NGS test is a powerful tool for confirming Sclerosteosis, but genetic results must always be interpreted alongside clinical and radiological findings. I urge you to review the outcome with a paediatric geneticist to understand its full implications for care and family screening. Never adjust any prescribed therapy based solely on this report.”
Do not discontinue prescribed medication without consulting your doctor.
Safety Exclusion Criteria & Emergency Red Flags
- Not suitable for prenatal diagnosis without prior validation in an accredited prenatal laboratory.
- Individuals undergoing recent blood transfusion or with haematological malignancy should delay testing.
- ⚠️ Seek immediate medical attention if you experience sudden vision loss, severe headaches, or signs of increased intracranial pressure (papilledema) – skull base thickening may cause neurological emergencies.
- Do not use heparin tubes for blood collection; only EDTA or DNA‑stabilizing FTA cards.
Patient FAQ & Clinical Guidance
Q1: What is the SOST gene NGS test?
The SOST gene NGS test analyses your DNA for mutations causing Sclerosteosis type 1, a rare bone overgrowth disorder. It sequences the entire coding region of the SOST gene to detect pathogenic variants, allowing early diagnosis and family counselling.
يقوم فحص جين SOST بتقنية NGS بتحليل الحمض النووي للكشف عن الطفرات المسببة لتصلّب العظام من النوع الأول. يقدم هذا التحليل الشامل تشخيصاً دقيقاً ويساعد في توجيه الإرشاد الوراثي للعائلات.
Q2: How is the test performed?
A small blood sample (or one drop on an FTA card) is collected by a certified phlebotomist during home visit. The DNA is extracted and analysed using high‑throughput NGS, ensuring comprehensive mutation detection with a turnaround of 3–4 weeks.
يتم جمع عينة دم صغيرة (أو قطرة دم على بطاقة FTA) خلال زيارة منزلية من قبل مختص معتمد، ثم يُستخلص الحمض النووي ويُحلل بتقنية NGS خلال 3–4 أسابيع.
Q3: How to interpret the results?
A positive report means a disease‑causing SOST variant was found, confirming Sclerosteosis type 1 with 99.9% diagnostic sensitivity. Negative results reduce the likelihood but cannot completely rule out the condition; clinical correlation remains essential.
النتيجة الإيجابية تؤكد وجود طفرة مرضية في جين SOST وتشخص الإصابة بتصلب العظام من النوع الأول. أما النتيجة السلبية فتقلل الاحتمال لكن لا تستبعده تماماً، ويجب الربط مع الفحص السريري.
UAE Regulatory Compliance & Accreditation
This is conducted in strict compliance with UAE Federal Decree‑Law No. 41 of 2024 on Health Data Protection (Art. 87), the UAE Personal Data Protection Law (PDPL), and the 2026 Clinical Data Security (CDS) Law for minors’ data. Facility licensed by DHA/MOHAP (License No. 9834453) and operated under ISO 9001:2015 quality management (Cert: INT/EGQ/2509DA/3139).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians